Marinus Pharmaceuticals (MRNS) PT Raised to $6 at Jefferies on Successful Rare Epilepsy Study
Tweet Send to a Friend
Jefferies analyst Andrew Tsai raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $6.00 (from $4.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
